how to successfully get off glp-1 When Pause or Stop a GLP-1: A Decision Framework What Happens When You Stop

Research continues into optimizing dosing protocols for different patient populations, including those with specific metabolic conditions

If you suspect you are experiencing side effects from your medication, you can report these through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)

How to Administer Tirzepatide Tirzepatide is administered as a subcutaneous injection once weekly

Personalized Feedback for Better Outcomes Remote patient monitoring enables a more personalized approach to weight loss management

Liraglutide suppresses TNF- and monocyte chemoattractant protein-1 (MCP-1) expression in monocytes derived from healthy participants

Scand J Gastroenterol 2018;53(12):142932